Johannesburg – The BRICS Health Ministers’ Meeting is scheduled for next week Friday, (4 August 2023), in South Africa, and will look at – among other issues – the development of nuclear medicine.
The Expert Forum provides a venue for specialists from BRICS countries to exchange their experience in nuclear medicine, including in the use of advanced scientific developments in radionuclide diagnostics and therapy of socially significant diseases.
Its key task is to discuss the development and manufacturing of medical devices, innovative radiopharmaceutical drugs, and the training of highly qualified personnel.
For two days, the Forum attendees will address the issues of nuclear medicine development in the BRICS countries and efficient cooperation to achieve a common goal: improving the quality of life and increasing the life expectancy of citizens.
In addition, the experts will discuss the establishment of the BRICS Nuclear Medicine Working Group and the development of a professional communication platform to discuss and implement advanced technology in nuclear medicine in the BRICS countries.
The agenda will also include developing the national and international legal framework to create convenient logistics between the BRICS countries for delivering radiopharmaceuticals and medical devices that contain radionuclides for medical and scientific purposes.
The International BRICS Expert Forum on Nuclear Medicine, which took place in Moscow on 20 July 2023 was attended by more than 200 representatives of the BRICS Interstate Group from Russia, Brazil, India, China, and South Africa.
The Forum was arranged by the Ministry of Health of the Russian Federation and the Rosatom State Atomic Energy Corporation.
The event was attended by the heads and leading scientists of the largest research medical centers, manufacturers of medical radioisotopes and radiopharmaceuticals from the BRICS countries, and representatives of state authorities in manufacturing radioisotope products for health care.
They included the Brazilian Nuclear Energy Research Institute (IPEN); Indian Board of Radiation and Isotope Technology (BRIT), Bhabha Atomic Research Centre (BARC), NTP Radioisotopes SOC Ltd. (South Africa), iThemba LABS (South Africa), China Isotope and Radiation Corporation (CIRC), Brazilian Society of Nuclear Medicine and Molecular Imaging, Society of Nuclear Medicine of India, Chinese Society of Nuclear Medicine (CSNM), and South African Society of Nuclear Medicine (SASNM).
Speaking at the occasion, Mikhail Murashko, Minister of Health of the Russian Federation, said: “Today, nuclear medicine is a crucial direction for the development of a high-tech, personalized approach to the diagnosis and treatment of diseases.
“The Russian Federation is one of the largest suppliers of radiopharmaceuticals. We have registered and approved 60 radiopharmaceutical drugs for medical use.
“At the same time, the BRICS countries have significant potential in the development and application of nuclear medicine methods and resources.
“Currently, there is a need to consolidate our efforts for more efficient implementation of nuclear medicine achievements in practical healthcare.”
Significant attention should be paid to the interaction between the largest medical centers in the BRICS countries specialising in the diagnosis and treatment of oncological, cardiological, endocrine, and other diseases, in which nuclear medicine technologies play an increasingly important role today.
This will make a significant contribution to improving the health of the population in all BRICS countries», the Minister of Health of Russia noted.
The experts were also addressed by Igor Obrubov, Director General of Rusatom Healthcare JSC (ROSATOM) who said: “At Rosatom, we consider the development of medical nuclear technology a strategic activity area. Also, as a socially responsible company, we see it as a way to contribute to our homeland’s wellbeing.
“We are open to joint projects for nuclear medical technology development with friendly nations and believe that only by uniting the efforts of the medical community, managers, scientists, and business can we jointly achieve the essential common goal: the widespread use of nuclear medicine for diagnosis and treatment.
“I am positive it will help take the healthcare in our countries to a new level of quality”.
At the press briefing, Rafael Lopez, Professor and President of the Brazilian Society of Nuclear Medicine and Molecular Imaging, said: “Nuclear medicine today is becoming the world leader in boosting innovative technology that may significantly contribute to increased life expectancy of the population”.
Lopez added: “That is why it is crucial to develop these technologies with international cooperation, given all the advanced experience of the BRICS countries.
“I hope that this format of international communication will become regular and allow us to expand joint activities between our nations aimed at developing nuclear technology for the benefit of medicine.”
